# Role of microRNAs in neutrophil migration

> **NIH NIH R35** · PURDUE UNIVERSITY · 2020 · $240,000

## Abstract

Summary:
Neutrophilic inflammation drives the immunopathology involved in numerous human diseases,
including those directly involving an immune component such as rheumatic arthritis and those
that are not obviously linked, such as diabetes, neurodegenerative disease and cancer. Recent
evidences suggest that neutrophils are long lived cells that disseminate inflammation, critically
regulate the magnitude of the inflammation and that bridge innate and adaptive immunities in
both sterile inflammation and infection. Thus, a successful strategy to prevent the initial
infiltration of neutrophils is expected to significantly improve inflammatory conditions and reduce
the risk of many modern diseases. Neutrophil motility is targeted in clinical settings to treat
inflammatory diseases such as gout and pericarditis. However, current drugs such as
corticosteroids and the microtubule destabilizing agent colchicine lack neutrophil specificity thus
are inevitably accompanied with adverse side effects. There is an urgent need to improve the
existing regimes, which is dependent on a better understanding of the neutrophil-intrinsic
mechanisms that specifically regulate neutrophil migration.
MicroRNAs are evolutionarily conserved, small non-coding RNAs that post-transcriptionally
regulate protein synthesis . MicroRNAs and anti-MicroRNAs have recently become strategies
for treating human diseases. Although a list of microRNAs are identified in human neutrophils,
their contributions in neutrophil migration as individuals or as a group have not been addressed.
The absence of such knowledge creates a missed opportunity to harness microRNAs as tools in
the prevention and treatment of inflammatory conditions.
Here we propose the first systemic survey of the function of microRNAs in regulating neutrophil
migration, aiming to identify and characterize microRNAs and anti-microRNAs with therapeutic
potentials in restraining neutrophilic inflammation. We will #1. Determine how microRNAs
collectively regulate neutrophil migration. #2. Screen for individual microRNAs that suppress
neutrophil migration. #3. Determine how individual miRNAs suppress neutrophil migration.
#4. Develop a tool to isolate neutrophil specific miRISC.
Our work used zebrafish, a vertebrate model organism that allow for screenings of neutrophil
intrinsic microRNAs for their contribution in regulating neutrophil migration, from the
hematopoietic tissue to a localized infection, which is not possible in cell culture or in mice. To
translate our findings to a more human health relevance setting, we will confirm our findings in
human neutrophil like cells and inflammatory mouse models.
Our contribution will be significant because it is expected to have broad translational importance
in the prevention and treatment of a wide range of inflammation related disease. Our preliminary
studies strongly suggest that we have collected all the essential tools and identified candidate
microRNAs to push this field forward...

## Key facts

- **NIH application ID:** 10151081
- **Project number:** 3R35GM119787-05S1
- **Recipient organization:** PURDUE UNIVERSITY
- **Principal Investigator:** Qing Deng
- **Activity code:** R35 (R01, R21, SBIR, etc.)
- **Funding institute:** NIH
- **Fiscal year:** 2020
- **Award amount:** $240,000
- **Award type:** 3
- **Project period:** 2016-08-11 → 2022-07-31

## Primary source

NIH RePORTER: https://reporter.nih.gov/project-details/10151081

## Citation

> US National Institutes of Health, RePORTER application 10151081, Role of microRNAs in neutrophil migration (3R35GM119787-05S1). Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/grant/nih/10151081. Licensed CC0.

---

*[NIH grants dataset](/datasets/nih-grants) · CC0 1.0*
